bit.bio Testimonials

"More physiologically relevant disease models will permit better and more predictable drug discovery, and will therefore improve the translation of medicines to the clinic."

"With our solid iPSC expertise, we were thrilled to find a cellular model that aligns seamlessly with our drug screening efforts. ioOligodendrocyte-like cells performed reliably and met all expectations. We especially appreciated bit.bio's detailed protocols and excellent scientific support, which made integration into our workflow both smooth and productive."